Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J M Valk

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Gene expression profiling in acute myeloid leukemiaLars Bullinger, Peter J M Valk
Current Opinion in Hematology|February 6, 2013
The evolving molecular genetic landscape in acute myeloid leukaemiaMathijs A Sanders, Peter J M Valk
Haematologica|March 30, 2019
Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemiaRoss L Levine, Peter J M Valk
British Journal of Haematology|January 6, 2016
Review: Aberrant EVI1 expression in acute myeloid leukaemiaAdil A Hinai, Peter J M Valk
Current Opinion in Hematology|December 18, 2004
Gene expression profiling in acute myeloid leukemiaPeter J M Valk, Ruud Delwel, Bob Löwenberg
Cancer Treatment and Research|March 23, 2010
Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemiaRoel G W Verhaak, Peter J M Valk
Haematologica|August 14, 2008
Exon 8 splice site mutations in the gene encoding the E3-ligase CBL are associated with core binding factor acute myeloid leukemiasSaman Abbas, Gabriëlle Rotmans, Bob Löwenberg, et al.
Blood|June 5, 2014
NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbfβ-SMMHC via activation of MEK/ERK axisLiting Xue, John A Pulikkan, Peter J M Valk, et al.
Blood|December 28, 2006
A recurrent in-frame insertion in a CEBPA transactivation domain is a polymorphism rather than a mutation that does not affect gene expression profiling-based clustering of AMLBas J Wouters, Irene Louwers, Peter J M Valk, et al.
The Journal of Molecular Diagnostics : JMD|November 30, 2024
BCR::ABL1 Deep Molecular Response Quantification and Transcript Type Identification in Chronic Myeloid Leukemia Using a US Food and Drug Administration-Approved Droplet-Based Digital PCR AssayCamille Kockerols, Peter J M Valk, Pauline Hogenbirk, et al.
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Gene expression profiling in acute myeloid leukemiaLars Bullinger, Peter J M Valk
Current Opinion in Hematology|February 6, 2013
The evolving molecular genetic landscape in acute myeloid leukaemiaMathijs A Sanders, Peter J M Valk
Haematologica|March 30, 2019
Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemiaRoss L Levine, Peter J M Valk
British Journal of Haematology|January 6, 2016
Review: Aberrant EVI1 expression in acute myeloid leukaemiaAdil A Hinai, Peter J M Valk
Current Opinion in Hematology|December 18, 2004
Gene expression profiling in acute myeloid leukemiaPeter J M Valk, Ruud Delwel, Bob Löwenberg
Cancer Treatment and Research|March 23, 2010
Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemiaRoel G W Verhaak, Peter J M Valk
Haematologica|August 14, 2008
Exon 8 splice site mutations in the gene encoding the E3-ligase CBL are associated with core binding factor acute myeloid leukemiasSaman Abbas, Gabriëlle Rotmans, Bob Löwenberg, et al.
Blood|June 5, 2014
NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbfβ-SMMHC via activation of MEK/ERK axisLiting Xue, John A Pulikkan, Peter J M Valk, et al.
Blood|December 28, 2006
A recurrent in-frame insertion in a CEBPA transactivation domain is a polymorphism rather than a mutation that does not affect gene expression profiling-based clustering of AMLBas J Wouters, Irene Louwers, Peter J M Valk, et al.
The Journal of Molecular Diagnostics : JMD|November 30, 2024
BCR::ABL1 Deep Molecular Response Quantification and Transcript Type Identification in Chronic Myeloid Leukemia Using a US Food and Drug Administration-Approved Droplet-Based Digital PCR AssayCamille Kockerols, Peter J M Valk, Pauline Hogenbirk, et al.
Pageof 20